Tandem Diabetes Care, Inc.
Clinical trials sponsored by Tandem Diabetes Care, Inc., explained in plain language.
Medical device company making insulin pumps for diabetes.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New insulin pump software aims to cut dangerous low blood sugar events
Disease control CompletedThis study tested an updated version of the Control-IQ system, which automatically adjusts insulin delivery for people with type 1 diabetes. Sixty-six adults and adolescents used the new software along with a continuous glucose monitor for several weeks. The main goal was to see …
Phase: NA • Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New tech aims to simplify diabetes management
Disease control CompletedThis study tested a smart insulin system called Control-IQ+ in 319 adults with type 2 diabetes who use insulin. The goal was to see if the technology helps control blood sugar better than standard care. Participants used the system for a period, and researchers measured changes i…
Phase: NA • Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New insulin system tested in hotel setting for type 1 diabetes
Disease control CompletedThis study tested a new insulin delivery system called Tandem Freedom in 10 adults with type 1 diabetes. Participants used their usual system at home for a week, then switched to the new system in a supervised hotel setting. The goal was to check safety and how well it controls b…
Phase: NA • Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New insulin system tested in hotel study – no severe events reported
Disease control CompletedThis small study tested a new insulin delivery system called Tandem Freedom in 10 adults with type 1 diabetes. Participants first used their usual system at home for a week, then switched to Tandem Freedom in a supervised hotel setting. The main goals were to check for severe low…
Phase: NA • Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New insulin set aims to last a full week – no more Every-Other-Day changes?
Disease control CompletedThis study tested a new insulin infusion set designed to be worn for up to 7 days instead of the usual 2-3 days. 260 adults with type 1 diabetes used the set at home for 12 wear periods. The goal was to see if the set could safely deliver insulin for a full week without causing h…
Phase: NA • Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC